About Evalytica
Evalytica is a company based in San Francisco (United States) founded in 2014 was acquired by Veradigm in February 2018. Evalytica offers products and services including Real World Evidence Analytics Platform, Veradigm EHR, and ePrescribe. Evalytica operates in a competitive market with competitors including ACTO, Definitive Healthcare, IMS Health, Axtria and Doceree, among others.
- Headquarter San Francisco, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evalytica
Evalytica offers a comprehensive portfolio of products and services, including Real World Evidence Analytics Platform, Veradigm EHR, and ePrescribe.
SaaS platform for efficient analysis of healthcare data sets
Software for clinical documentation and workflow support
Solution for electronic prescribing including controlled substances
Funding Insights of Evalytica
Detailed funding history for Evalytica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Evalytica
Evalytica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Veradigm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based administrative suite solutions for healthcare organizations
|
Locked | Locked | Locked |
Investor details for Evalytica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evalytica
Investment portfolio details for Evalytica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evalytica
Detailed financials for Evalytica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evalytica Comparisons
Peer comparison for Evalytica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evalytica
Evalytica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACTO, Definitive Healthcare, IMS Health, Axtria and Doceree, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and SaaS-based educational platform for life sciences is provided.
|
|
| Locked | Locked | Locked |
Offers market intelligence and data analytics for healthcare providers and physicians
|
|
| Locked | Locked | Locked |
SaaS and AI-based market intelligence is provided for healthcare companies.
|
|
| Locked | Locked | Locked |
Data analytics and AI solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of pharmaceutical advertising and healthcare marketing platform
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
Detailed competitors of Evalytica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evalytica
Complete news archive for Evalytica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evalytica
Evalytica was founded in 2014.
Evalytica is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jon Williams is the current CEO of Evalytica.
Evalytica is a cloud-based, software as a service (SaaS) platform for the analysis of healthcare data. Operating as part of Evidera, it supports near real-time analyses of virtually any type of real-world data sources such as claims, electronic medical records, and registry data. It contains a repository of pre-built analysis apps that provides analytic capabilities in the areas such as drug safety, epidemiology, health economics, and comparative effectiveness. It also includes a programming interface for custom analytic app development. Its collaboration features, such as a library of reusable patient cohort and health outcomes can be curated, searched, shared and re-used across users and analysis communities. Also, using the software Evidera offers consulting services for life sciences organizations of all sizes.
Evalytica offers Real World Evidence Analytics Platform, Veradigm EHR, and ePrescribe.
Evalytica has 1 investor. Key investors include Veradigm.